Following Phase 3 trials, the drug candidate manufacturer can apply for a New Drug Application (NDA) from the FDA. The FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback